Silverback Therapeutics shares owned by Clearline Capital
Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Clearline Capital
from 13F filings
Historical chart of Clearline Capital investment in Silverback Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Silverback Therapeutics held by Clearline Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Silverback Therapeutics by Clearline Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $1.0M | 272k | 3.78 |
| 2023-06-30 | $409k | 61k | 6.70 |